Evidence map›Paper›PMID 36671862›Full record

ReviewBiosensors2022

Raman Spectroscopy on Brain Disorders: Transition from Fundamental Research to Clinical Applications.

Jeewan C Ranasinghe, Ziyang Wang, Shengxi Huang

Open access · goldAbstract readReview
In one paragraph

Review in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Advancements in Neurosurgical Intraoperative Histology.Tomography (Ann Arbor, Mich.) · 2024
    Review
  11. Current Trends of Raman Spectroscopy in Clinic Settings: Opportunities and Challenges.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeewan C RanasingheDepartment of Electrical and Computer Engineering, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-7744-5644
Ziyang WangDepartment of Electrical and Computer Engineering, Rice University, Houston, TX 77005, USA.
Shengxi HuangDepartment of Electrical and Computer Engineering, Rice University, Houston, TX 77005, USA.ORCID 0000-0002-3618-9074
Rice University · US

Funding

SCH: AI-Enhanced Multimodal Sensor-on-a-chip for Alzheimer's Disease DetectionR01AG077016 · NIA · PENNSYLVANIA STATE UNIVERSITY, THE · PI HU, JUEJUN, MA, FENGLONG · 2022 to 2025
$1.2M
National Science Foundation ECCS-1943895National Science Foundation ECCS-2246564NIA NIH HHS R01 AG077016NIH HHS 1R01AG077016-01
6 · The paper itself

Abstract

Brain disorders such as brain tumors and neurodegenerative diseases (NDs) are accompanied by chemical alterations in the tissues. Early diagnosis of these diseases will provide key benefits for patients and opportunities for preventive treatments. To detect these sophisticated diseases, various imaging modalities have been developed such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). However, they provide inadequate molecule-specific information. In comparison, Raman spectroscopy (RS) is an analytical tool that provides rich information about molecular fingerprints. It is also inexpensive and rapid compared to CT, MRI, and PET. While intrinsic RS suffers from low yield, in recent years, through the adoption of Raman enhancement technologies and advanced data analysis approaches, RS has undergone significant advancements in its ability to probe biological tissues, including the brain. This review discusses recent clinical and biomedical applications of RS and related techniques applicable to brain tumors and NDs.

Indexed as

Brain NeoplasmsSpectrum Analysis, RamanHumansMagnetic Resonance ImagingPositron-Emission TomographyTomography, X-Ray Computedbiomarker identificationbrain disordersclinical treatmentRaman spectroscopystatistical analysis

Identifiers

PMID36671862
PMCPMC9855372
OpenAlexW4312202346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.